Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 3,814,000 | 3,538,000 | 3,483,000 | 3,287,000 | 3,271,000 |
| Cost of Goods | 126,000 | 135,000 | 119,000 | 118,000 | 111,000 |
| Gross Profit | 3,688,000 | 3,403,000 | 3,364,000 | 3,169,000 | 3,160,000 |
| Operating Expenses | 2,202,000 | 3,185,000 | 2,166,000 | 2,084,000 | 1,849,000 |
| Operating Income | 1,486,000 | 218,000 | 1,198,000 | 1,085,000 | 1,311,000 |
| Interest Expense | 192,000 | 166,000 | 142,000 | 127,000 | 126,000 |
| Other Income | 13,000 | 978,000 | 75,000 | 33,000 | -7,000 |
| Pre-tax Income | 1,307,000 | 1,030,000 | 1,131,000 | 991,000 | 1,178,000 |
| Income Tax | 262,000 | 184,000 | 1,212,000 | 3,000 | 77,000 |
| Net Income Continuous | 1,045,000 | 846,000 | -81,000 | 988,000 | 1,101,000 |
| Net Income | $1,045,000 | $846,000 | $-81,000 | $988,000 | $1,101,000 |
| EPS Basic Total Ops | 1.46 | 1.13 | -0.10 | 1.26 | 1.41 |
| EPS Basic Continuous Ops | 1.46 | 1.13 | -0.09 | 1.26 | 1.41 |
| EPS Diluted Total Ops | 1.43 | 1.10 | -0.08 | 1.21 | 1.36 |
| EPS Diluted Continuous Ops | 1.43 | 1.10 | -0.08 | 1.21 | 1.36 |
| EPS Diluted Before Non-Recurring Items | 1.86 | 1.61 | 1.87 | N/A | N/A |
| EBITDA(a) | $1,656,000 | $344,000 | $1,314,000 | $1,200,000 | $1,435,000 |